Forget the Oil Crash – Crush the Market With Biotech StocksAdded by Oliver Wright on December 20, 2014.Saved under MoneyTags: Capitalism, Investing, Monetary PolicyThis post Forget the Oil Crash – Crush the Market With Biotech Stocks appeared first on Daily Reckoning.The financial media is playing the “when will oil bottom?” game to help fill the 24-hour news cycle—but that’s not […]
The financial media is playing the “when will oil bottom?” game to help fill the 24-hour news cycle—but that’s not going to make you money.So, today I have a trade that will…Sure, crude just took a breather to plug the leaks. It even jumped a couple of bucks. But when all was said and done yesterday, oil landed right back […]
Many biotech stocks have been breaking out over the past two months.Newlink Genetics Corp and Incyte Corporation both skyrocketed in October.After that, stocks of Ariad Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. both had nice, quick pops last month.Then there was Kite Pharma Inc’s huge jump earlier this month.So, Who’s Next?The Company: Sangamo Biosciences, Inc.Ticker Symbol: (NASDAQ: SGMO)Sector: HealthcareIndustry: BiotechnologySangamo focuses […]
With the holiday season coming up, it’s been a relatively quiet week for the biotech sector with very few pipeline and regulatory updates. However, companies like Sophiris (SPHS – Snapshot Report) and Cyclacel saw their shares plunging on disappointing pipeline updates.Recap of the Week’s Most Important Stories1. Sophiris faced a major pipeline setback following an interim analysis of an ongoing […]
With the holiday season coming up, it’s been a relatively quiet week for the biotech sector with very few pipeline and regulatory updates. However, companies like Sophiris (SPHS – Snapshot Report) and Cyclacel saw their shares plunging on disappointing pipeline updates.Recap of the Week’s Most Important Stories1. Sophiris faced a major pipeline setback following an interim analysis of an ongoing […]
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.
Bank Of America Raises Dr Pepper Snapple Group Price Target
UPDATE: Citigroup Initiates Coverage On Leidos Holdings, Likes Cash Return Potential
Continue reading:
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C …
[…]
Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.Copyright ©2014 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.
View post:
3 Ways to Play the Bounce in Biotech Stocks (MRK, GILD, PTCT …
[…]
Kyle Anderson: When researching the best biotech stocks to buy, investors often look for companies that will cure terrible, chronic diseases.Until recently, these biotech stocks have been elusive.Have you ever wondered how billionaires continue to get RICHER, while the rest of the world is struggling?“I study billionaires for a living. To be more specific, I study how these investors generate such huge and consistent […]
When researching the best biotech stocks to buy, investors often look for companies that will cure terrible, chronic diseases.Until recently, these biotech stocks have been elusive.”Modern medicine, for all of its sophisticated drugs, complex gadgets, and amazing surgical procedures, rarely cures anything,” Money Morning‘s Biotech Investing Specialist Ernie Tremblay said. “It treats. It manages. It postpones the inevitable. But return […]
Mergers and acquisitions show no signs of slowing down in the biotech sector with a $3.5 billion acquisition agreement being announced. Meanwhile, Biogen (BIIB – Analyst Report) is advancing towards developing a treatment for Alzheimer’s disease.Recap of the Week’s Most Important Stories1. Biogen is set to move its experimental Alzheimer’s disease treatment, BIIB037, into late-stage testing based on promising interim […]
